| |
Media
Room - News Release
CONTACT: Geri
M. Berdak
The Solae Company
gberdak@solae.com
THE SOLAE COMPANY DEBUTS AS GLOBAL SPECIALTY FOOD INGREDIENT SUPPLIER
The Mission: Innovate and Mainstream Value-Added, Plant-Based Ingredients;
Expand Products and Services to Customers to Meet Growing Demand
ST. LOUIS, April 2, 2003 – The Solae Company today debuts
as one of the world's premier developers and marketers of branded,
plant-based, specialty food, feed, and industrial ingredients.
Initially, the company's annual revenues are expected to exceed
$800 million.
The Solae Company is being formed through a two-stage process.
Bunge Limited and DuPont have concluded definitive agreements and
contributed assets comprising DuPont's Protein Technologies business
and Bunge's North American and European ingredients operations.
In the second stage, Bunge will contribute its Brazilian ingredients
operations. Bunge will sell its majority interest in these operations
to The Solae Company, which then will extend an offer to acquire
the interest of minority shareholders.
The Solae Company will focus on significantly growing the global
business in plant- based, specialty food ingredients, initially
addressing soy protein and lecithin, and expanded offerings of
products and services that help customers compete and prosper.
With manufacturing operations in four major regions and six technical
centers around the world, The Solae Company offers knowledgeable
staff, customer support, and technical capabilities, combining
local market insights with global expertise and experience to create
customized solutions. The Solae Company's long-term aim is to incorporate
great-tasting, value-added, specialty food ingredients into the
world's menu in every day meat products, beverages, cereals, and
a wide range of processed foods.
"From the outset, The Solae Company is a different kind of
business for the specialty ingredients and agricultural industries," said
Stephan Tanda, chief executive officer of The Solae Company. "The
Solae Company begins operating with the market orientation, innovative
capability, scale, and scientific experience necessary to be a
strong contender in the fast-growing, global market for specialty
food ingredients."
"One of most important factors that distinguishes The Solae
Company is the track record of its predecessors as trusted innovators
for, and advisors to, the food and beverage industries," Tanda
continued. "We have built this reputation by providing food
and beverage manufacturers with creative ideas for new products,
by improving efficiencies in food manufacturing processes and supply
chains, and by developing complete business solutions.
"Another factor that sets The Solae Company apart is the
more than 30 years of scientific expertise it inherits," said
Tanda. The Solae Company's soy proteins are the proteins of choice
used in approximately 400 completed or ongoing medical studies
about the efficacy of soy with respect to heart health, women's
health, cancer, weight management, and blood pressure management.
The Solae Company will extend its scientific leadership on July
12-16, 2003, at the International Food Technology (IFT) conference
in Chicago, where it will host an industry symposium about the
role of plant-based, specialty food ingredients in reducing the
rapidly increasing incidence of obesity in the United States.
"The demand for plant-based, specialty ingredients for meats,
foods, and beverages is growing at healthy annual rates. The Solae
Company has the scale and capacity to compete in these fast-growing
market segments, and the firm will continue to pioneer the development
of plant-based, specialty ingredients," Tanda concluded.
The Solae Company serves food manufacturers, retailers, and consumers
in 100 countries worldwide including the United States and Canada,
Europe and Middle East, Latin America and the Asia/Pacific region.
Forward-Looking Statements
This news release contains forward-looking statements based on
management's current expectations, estimates and projections.
All statements that address expectations or projections about
the future, including statements about strategy for growth, product
development, market position, expected expenditures and financial
results are forward-looking statements. Some of the forward-looking
statements may be identified by words like "many," "will," "expects," "anticipates," "plans," "intends," "aims," "projects," "indicates," and
similar expressions. These statements are not guarantees of future
performance and involve a number of risks, uncertainties and
assumptions. Many factors, including those discussed more fully
in this release and in documents filed with the Securities and
Exchange Commission by DuPont and Bunge could cause results to
differ materially from those stated. These factors include, but
are not limited to, changes in the laws, regulations, policies,
economic and political conditions, including inflation, interest
and foreign currency exchange rates of countries in which the
companies do business; competitive pressures; ability to complete,
integrate and benefit from acquisitions, divestitures, joint
ventures and alliances; cost of raw materials, research and development
of new products, including regulatory approval and market acceptance;
and industry conditions, including the seasonality and cyclicality
of agricultural products.
# # #
|
|
|
|